Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Durberg Meds AB
AB
Active
Org 5593901134
Stampgatan 56 C
General medical practice activities · NACE 8621
Est. 2022
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 798K
-49% vs 2024
EBITDA margin
8.7%
-89% vs 2024
Equity ratio
35.6%
Financial strength
Net profit 2025
SEK 220K
-61% vs 2024
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2023
1M
0%
2024
0M
-100%
2025
Key figures
Annual report 2025
Revenue
SEK 798K
-49%
EBITDA
SEK 70K
-89%
Net profit
SEK 220K
-61%
Total assets
SEK 1,1M
-27%
Equity
SEK 380K
-60%
Employees
2
—
Company information
Legal name
Durberg Meds AB
Org number
5593901134
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 juli 2022
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget erbjuder och förmedlar konsulttjänster inom hälsovård, som inkluderar sluten- och öppenvård samt digitala tjänster.
Contact
Address
Stampgatan 56 C
Email
samer.aldury@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Göteborg
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2023
2M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
0M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
1 889
1 559
798
Staff expenses
−115
−367
−273
EBITDA
1 342
649
70
Depreciation & amort.
—
—
−5
EBIT
1 342
649
65
Net financials
1
57
197
Profit before tax
1 343
706
261
Tax
−279
−141
−41
Net profit
1 064
565
220
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
1 368
1 459
1 067
Equity
1 089
959
380
Long-term debt
—
—
—
Short-term debt
279
499
687
Total debt
279
499
687
Financial ratios
5-year trend
EBITDA margin
8.7%
This company
15.8%
Market median
-45% vs market
2023
2025
Equity ratio
35.6%
This company
38.2%
Market median
+7% vs market
2023
2025
Return on equity
58.0%
This company
18.4%
Market median
+215% vs market
2023
2025
Net profit margin
27.6%
This company
8.1%
Market median
+241% vs market
2023
2025
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
2023
2025
Debt / equity
1.81×
This company
0.62×
Market median
-192% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-18 – 2023-08-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
SA
Samer Al-Dury
Chairman
2024
NN
Nelly Nali Kanberg Al-Dury
Board of Directors
2022
YM
Yassir Mohammed Hussein Al-Oleiw
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Durberg Meds AB also hold positions in
0
other companies.
Person
Role here
Other companies
Samer Al-Dury
Chairman
0 companies
Nelly Nali Kanberg Al-Dury
Board of Directors
0 companies
Yassir Mohammed Hussein Al-Oleiw
Deputy Board Member
0 companies